The battle for Commerzbank has taken an unexpected regulatory turn. Germany’s financial watchdog, BaFin, has ordered UniCredit to cease what it described as a “sensationalist and inappropriate” advertising campaign targeting the Frankfurt-based lender. The Italian bank had taken to social media to brand Commerzbank as “neglected” and “unsafe,” a tactic that BaFin ruled violated takeover law. The ads, which were accessible across the EU, have now been taken down. Market observers view the rhetoric from UniCredit CEO Andrea Orcel as a calculated effort to depress the stock price ahead of a potential formal bid.
The regulatory clampdown comes at a critical juncture. UniCredit currently holds just under 30% of Commerzbank’s shares, and sources indicate the Italians are preparing to launch a formal offer in early May. Crossing the 30% threshold would trigger a mandatory tender offer for all remaining shareholders. Commerzbank’s management and the German government remain firmly opposed to a takeover.
A Dense Calendar of Catalysts
May promises to be a defining month for Commerzbank, with a packed schedule of events that will test the bank’s standalone strategy. On May 8, the lender is due to report first-quarter results, followed by its annual general meeting in Wiesbaden on May 20. Shareholders will vote on a proposed dividend of €1.10 per share, a significant increase from prior payouts. The ex-dividend date would fall on May 21. Also on the agenda is authorization for further share buybacks. Investors looking to vote must hold shares by April 28.
Behind the scenes, management is working on a strategic update for 2030. According to press reports, the board is planning additional job cuts as part of a broader cost-reduction drive. The full details are expected to be unveiled in May.
Should investors sell immediately? Or is it worth buying Commerzbank?
Meanwhile, the broader banking sector is watching the European Central Bank, which will announce its next interest rate decision on April 30. Market opinion is sharply divided, with some analysts expecting a pause and others betting on another hike. The outcome will have a direct impact on Commerzbank’s earnings outlook.
Analyst Optimism Amid Technical Pressure
Despite the regulatory noise, at least one analyst sees a floor under the stock. Barclays’ Flora Bocahut recently upgraded Commerzbank to “Overweight” and raised her price target sharply to €42. Her rationale: UniCredit’s advance provides downside protection for the share price.
The stock closed Friday at €33.94, posting a weekly loss of nearly 6%. Yet on a 12-month basis, it still trades roughly 44% higher. The 50-day moving average at €33.04 marks a key technical support level. With a relative strength index of 73.3, the shares are currently in overbought territory, leaving them vulnerable to a pullback.
If UniCredit does fire the starting gun on a formal bid in early May, the Italian bank will be forced to overhaul its communications strategy to comply with BaFin’s strict guidelines. For now, the German regulator has drawn a clear red line, and any further violations could result in a hefty fine.
Ad
Commerzbank Stock: Buy or Sell?! New Commerzbank Analysis from April 26 delivers the answer:
The latest Commerzbank figures speak for themselves: Urgent action needed for Commerzbank investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 26.
Commerzbank: Buy or sell? Read more here...












